Short answer · Medically reviewed summary · Last updated: 2026-05-08
The primary goal of Alport Syndrome treatment is to delay the progression of chronic kidney disease (CKD) by using medications that reduce protein leakage into the urine. While there is no cure, current clinical guidelines emphasize early intervention with renin-angiotensin-aldosterone system (RAAS) inhibitors to protect kidney function and preserve long-term health. What are the first-line medical treatments for Alport Syndrome? For patients diagnosed with Alport Syndrome, the gold standard for treatment is the use of ACE inhibitors (such as ramipril or lisinopril).
2 people with Alport Syndrome have shared their first-person experience on this question at DiseaseMaps.
What are the best treatments for Alport Syndrome?
Treatments for Alport Syndrome: what real patients say works for them, alongside a medically reviewed overview citing sources like NIH GARD and Orphanet.
The primary goal of Alport Syndrome treatment is to delay the progression of chronic kidney disease (CKD) by using medications that reduce protein leakage into the urine. While there is no cure, current clinical guidelines emphasize early intervention with renin-angiotensin-aldosterone system (RAAS) inhibitors to protect kidney function and preserve long-term health.
What are the first-line medical treatments for Alport Syndrome?
For patients diagnosed with Alport Syndrome, the gold standard for treatment is the use of ACE inhibitors (such as ramipril or lisinopril). These medications are effective at lowering blood pressure within the kidneys and reducing proteinuria (protein in the urine), which is a hallmark of Alport Syndrome. In some cases, physicians may also prescribe ARBs (angiotensin II receptor blockers) or mineralocorticoid receptor antagonists to further slow the decline of kidney function.
Which specialists should be on an Alport Syndrome care team?
Managing Alport Syndrome requires a multidisciplinary team to address the systemic nature of the condition, which can affect the kidneys, ears, and eyes. Your care team should ideally include:
- Nephrologist: To monitor kidney function and manage blood pressure medications.
- Ophthalmologist: To monitor for specific retinal changes or lens abnormalities.
- Audiologist/ENT: To conduct regular hearing screenings, as sensorineural hearing loss is common.
- Genetic Counselor: To help families understand the inheritance patterns of Alport Syndrome.
Are there emerging therapies for Alport Syndrome?
Research into Alport Syndrome is rapidly evolving. Current clinical trials are investigating therapies aimed at addressing the underlying collagen IV defect. Researchers are studying novel anti-fibrotic agents and chaperone therapies that may help stabilize the basement membrane. Patients are encouraged to consult clinicaltrials.gov to see if they meet the criteria for ongoing studies related to Alport Syndrome.
Next steps
- Consult a nephrologist to discuss a personalized treatment plan based on your specific genetic mutation.
- Join the DiseaseMaps.org community to connect with the 115 members already sharing their journey with Alport Syndrome.
- Maintain a consistent schedule of blood and urine tests to monitor protein levels.
Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice, diagnosis, or treatment; always consult with your personal healthcare team for decisions regarding your health.
References
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIH Genetic and Rare Diseases Information Center (GARD)
- Alport Syndrome Foundation
- Orphanet: Portal for rare diseases and orphan drugs
Our organization is conducting a single, pivotal registrational Phase 2/3 study named CARDINAL to evaluate the safety and efficacy of bardoxolone methyl in patients with chronic kidney disease (CKD) caused by Alport syndrome.
Posted Feb 6, 2018 by Reata Pharmaceuticals - CARDINAL Study for Alport Syndrome
Posted Sep 18, 2017 by Mark 800
